Воспаление при атеросклерозе: от теории к практике

24. Swirski, F.K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F.W., Weissleder, R., & Pittet, M.J. (2007). Ly-6C hi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. The Journal of clinical investigation, 117(1), 195-205.

25. An, G., Wang, H., Tang, R., Yago, T., McDaniel, J.M., McGee, S., ..., & Xia, L. (2008). PSGL-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation, 117(25), 3227.

26. Hansson, G.K., & Libby, P (2006). The immune response in atherosclerosis: a doubleedged sword. Nature reviews immunology, 6(7), 508-519.

27. Hansson, G.K. (2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 552(16), 1685-1695.

28. Schulte, S., Sukhova, G.K., & Libby, P (2008). Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. The American journal of pathology, 172(6), 1500-1508.

29. Mor, A., Planer, D., Luboshits, G., Afek, A., Metzger, S., Chajek-Shaul, T., ..., & George, J. (2007). Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 27(4), 893-900.

30. Han, S.F., Liu, P., Zhang, W., Bu, L., Shen, M., Li, H., ..., & Jia, G.L. (2007). The opposite-direction modulation of CD4+ CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clinical immunology, 124(1), 90-97.

31. Palladino, M.A., Bahjat, F.R., Theodorakis, E.A., & Moldawer, L.L. (2003). Anti-TNFa therapies: the next generation. Nature reviews Drug discovery, 2(9), 736-746.

32. Kume, T., Okura, H., Yamada, R., Kawamoto, T., Watanabe, N., Neishi, Y., ..., & Yoshida, K. (2009). Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography. Circulation Journal

33. Kashiwagi, M., Tanaka, A., Kitabata, H., Tsujioka, H., Matsumoto, H., Arita, Y., ..., & Ikejima, H. (2009). Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome. Circulation Journal, 73(7), 1291-1295.

34. Mach, F., Sauty, A., Iarossi, A.S., Sukhova, G.K., Neote, K., Libby, P., & Luster, A.D. (1999). Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. The Journal of clinical investigation, 104(8), 1041-1050.

35. Heller, E.A., Liu, E., Tager, A.M., Yuan, Q., Lin, A.Y., Ahluwalia, N., ..., & Moore, K.J. (2006). Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation, 113(19), 2301-2312.

36. Van Wanrooij, E.J., de Jager, S.C., van Es, T., de Vos, P., Birch, H.L., Owen, D.A., ..., & Kuiper, J. (2008). CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 28(2), 251-257.

37. Mach, F., Schonbeck, U., Bonnefoy, J.Y., Pober, J.S., & Libby, P. (1997). Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 96(2), 396-399.

38. Mach, F., Schonbeck, U., Sukhova, G.K., Bourcier, T., Bonnefoy, J.Y, Pober, J.S., & Libby, P. (1997). Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proceedings of the National Academy of Sciences, 94(5), 1931-1936.

39. Amento, E.P., Ehsani, N., Palmer, H., & Libby, P (1991). Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis and thrombosis: a journal of vascular biology, 11(5), 1223-1230.

40. Hedley, A.A., Ogden, C.L., Johnson, C.L., Carroll, M.D., Curtin, L.R., & Flegal, K. M. (2004). Prevalence of overweight and obesity among US children, adolescents, and adults, 19992002. Jama, 291(23), 2847-2850.

41. Shiraishi, J., Kohno, Y., Sawada, T., Nishizawa, S., Arihara, M., Hadase, M., ..., & Shigeta, M. (2006). Relation of obesity to acute myocardial infarction in Japanese patients. Circulation Journal, 70(12), 1525-1530.

42. Chaulin, A.M., Grigoryeva, Yu.V., & Duplyakov, D.V. (2020). The Participation of Catecholamines in the Pathogenesis of Diabetic Cardiomyopathy. Medicine in Kuzbass, (1), 11-18.

43. Oda, E. (2007). CRP may be superior to anthropometric markers of obesity. Circulation Journal, 71(8), 1332-1333.

44. Chaulin, A.M., Grigoryeva, Yu.V., & Duplyakov, D.V. (2020). Comorbidity: chronic obstructive pulmonary disease and cardiovascular diseases. Practical medicine, 18(1), 26-31.

45. Maeda, K., Okubo, K., Shimomura, I., Mizuno, K., Matsuzawa, Y., & Matsubara, K. (1997). Analysis of an expression profile of genes in the human adipose tissue. Gene, 190(2), 227-235.

46. Rocha, V.Z., & Libby, P. (2008). The multiple facets of the fat tissue. Thyroid, 18(2), 175-183.

47. Gabay, C., & Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. New England journal of medicine, 340(6), 448-454.

48. Yudkin, J.S., Kumari, M., Humphries, S.E., & Mohamed-Ali, V. (2000). Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis, 148(2), 209214.

49. Libby, P., & Ridker, P.M. (1999). Novel inflammatory markers of coronary risk: theory versus practice.

50. Lemieux, I., Pascot, A., Prud'homme, D., Almdras, N., Bogaty, P., Nadeau, A., ... & Despres, J.P (2001). Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology, 21(6), 961-967.

51. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., & Ferrante, A.W. (2003). Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation, 112(12), 1796-1808.

52. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., ... & Chen, H. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation, 112(12), 1821-1830.

53. Wu, H., Ghosh, S., Perrard, X.D., Feng, L., Garcia, G.E., Perrard, J.L., ... & Ballantyne, C.M. (2007). T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation, 115(8), 1029.

54. Kintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., ... & Hauner, H. (2008). T-lymphocyte infiltration in visceral adipose tissue: a primary event in adiposetissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, thrombosis, and vascular biology, 28(7), 1304-1310.

55. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., ... & Mathis, D. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature medicine, 15(8), 930-939.

56. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., ..., & Yoshimura, K. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature medicine, 15(8), 914-920.

57. Rocha, V.Z., Folco, E.J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A.H., & Libby, P (2008). Interferony, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circulation research, 103(5), 467-476.

58. Hu, E., Liang, P., & Spiegelman, B.M. (1996). AdipoQ is a novel adipose-specific genedysregulated in obesity. Journal of biological chemistry, 271(18), 10697-10703.

59. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H.F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological chemistry, 270(45), 26746-26749.

60. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPoseMost abundant Gene transcript 1). Biochemical and biophysical research communications, 221(2), 286-289.

61. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (2012). cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (Adipose Most Abundant Gene Transcript 1) (Reprinted from Biochemical and biophysical research communications, v. 221, p. 286-289, 1996). Biochemical and biophysical research communications, 425(3), 556-559.

62. Shibata, R., Ouchi, N., & Murohara, T. (2009). Adiponectin and Cardiovascular Disease. Circulation Journal, 73(4), 608-614.

63. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.I., ..., & Kuriyama, H. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and biophysical research communications, 257(1), 79-83.

64. Okamoto, Y, Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006). Adiponectin: a key adipocytokine in metabolic syndrome. Clinical science, 110(3), 267-278.

65. Okamoto, Y., Folco, E.J., Minami, M., Wara, A.K., Feinberg, M.W., Sukhova, G.K., ... & Libby, P (2008). Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circulation research, 102(2), 218-225.

66. Ridker, P.M., Rifai, N., Clearfield, M., Downs, J.R., Weis, S.E., Miles, J.S., & Gotto Jr, A.M. (2001). Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. New England Journal of Medicine, 344(26), 1959-1965.

67. Ridker, P.M., & Cook, N.R. (2013). Statins: new American guidelines for prevention of cardiovascular disease. The Lancet, 382(9907), 1762-1765.

68. Glynn, R.J., Danielson, E., Fonseca, F.A., Genest, J., Gotto Jr, A.M., Kastelein, J.J., ..., & Nordestgaard, B.G. (2009). A randomized trial of rosuvastatin in the prevention of venous thromboembolism. New England Journal of Medicine, 360(18), 1851-1861.

Размещено на Allbest.Ru